Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Medicine|July 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNPCristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, et al.United European Gastroenterology Journal|December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA RegistryMíriam Mañosa, Margalida Calafat, Elena Ricart, et al.Inflammatory Bowel Diseases|February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN StudyMaría Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.Journal of Crohn'S & Colitis|May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort StudyIvan Guerra, Luis Bujanda, Jesús Castro, et al.Journal of Clinical Medicine|August 12, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on UstekinumabMaría Chaparro, Iria Baston-Rey, Estela Fernández Salgado, et al.Alimentary Pharmacology & Therapeutics|August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDACristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.Alimentary Pharmacology & Therapeutics|June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registryRocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.Alimentary Pharmacology & Therapeutics|September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES studyMaría Chaparro, Sandra Hermida, Diana Acosta, et al.Pageof 4